New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Male Birth Control on the Horizon

A new male contraceptive gel designed to be less invasive than a vasectomy has been found to work successfully in primates.

Vasalgel Male Contraceptive / Image: Parsemus Foundation
Vasalgel Male Contraceptive / Image: Parsemus Foundation

A recent article from The Guardian suggests men will soon be able to take on the burden of birth control. A new product called Vasalgel was found to be 100% effective at preventing conception in rhesus monkeys. The non-hormonal contraceptive is designed to be reversible and less invasive than a vasectomy. Once injected, it forms a soft gel barrier that blocks sperm from passing through the Vas deferens. Sperm are too large to pass through the gel and are reabsorbed into the body; neither sperm production nor hormone levels are affected.

Last year, The World Health Organization investigated a male hormonal contraceptive jab that claimed to be as effective as the female pill, but a variety of unwanted side effects prevented the product from launching

The Vasalgel work was funded by The Parsemus Foundation, a non-profit that plans to begin human trials once funding is secured.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub